![Carol Schafer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Carol Schafer
Direktor/Vorstandsmitglied bei
INSMED INCORPORATED
Vermögen: 7 Mio $ am 30.06.2026
Profil
Carol Anne Schafer currently serves as Independent Director at Insmed, Inc. since 2020, Immunome, Inc. since 2024, and Kura Oncology, Inc. since 2021.
Ms. Schafer is also Director at Onegoal New York since 2019 and Managing Partner at Hyphen Advisors LLC since 2018.
Former roles include Vice Chairman-Equity Capital Markets at Wells Fargo Securities LLC from 2007 to 2018, Independent Director at Idera Pharmaceuticals, Inc. from 2018 to 2022, Independent Director at Five Prime Therapeutics, Inc. from 2019 to 2021, Independent Director at Repare Therapeutics, Inc. from 2019 to 2026, VP-Finance, Business Development & Communications at Lexicon Pharmaceuticals, Inc. from 2003 to 2007, and MD, VP & Head-Equity Capital Markets at J.P.
Morgan & Co., Inc. (Old) from 1986 to 2003.
Education includes undergraduate studies at Boston College and an MBA from The Leonard N Stern School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
INSMED INCORPORATED 0.03% | 13.05.2026 | 63’317 ( 0.03% ) | 7 Mio $ | 30.06.2026 |
IMMUNOME, INC. -.--% | 10.06.2026 | 0 ( -.--% ) | - $ | 30.06.2026 |
KURA ONCOLOGY, INC. -.--% | 04.06.2026 | 0 ( -.--% ) | - $ | 30.06.2026 |
Aktive Positionen von Carol Schafer
| Unternehmen | Position | Beginn |
|---|---|---|
| INSMED INCORPORATED | Direktor/Vorstandsmitglied | 01.04.2020 |
| KURA ONCOLOGY, INC. | Direktor/Vorstandsmitglied | 03.06.2021 |
| IMMUNOME, INC. | Direktor/Vorstandsmitglied | 02.01.2024 |
Hyphen Advisors LLC | Vorstandsvorsitzender | 01.01.2018 |
Onegoal New York
 Onegoal New York Miscellaneous Commercial ServicesCommercial Services Operates social services organization | Direktor/Vorstandsmitglied | 01.03.2019 |
Ehemalige bekannte Positionen von Carol Schafer
| Unternehmen | Position | Ende |
|---|---|---|
| REPARE THERAPEUTICS INC. | Direktor/Vorstandsmitglied | 28.01.2026 |
Idera Pharmaceuticals, Inc.
 Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Direktor/Vorstandsmitglied | 28.09.2022 |
| FIVE PRIME THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 16.04.2021 |
Wells Fargo Securities LLC
 Wells Fargo Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 01.09.2018 |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Carol Schafer
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
99
Beziehungen ersten Grades
13
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 13 |
|---|---|
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Health Technology |
Lexicon Pharmaceuticals, Inc.
 Lexicon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Insmed, Inc.
 Insmed, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases | Health Technology |
Five Prime Therapeutics, Inc.
 Five Prime Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops protein therapeutics for cancer and inflammatory diseases | Health Technology |
Immunome, Inc.
 Immunome, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which discovers, develops and commercializes antibody therapeutics | Health Technology |
Kura Oncology, Inc.
 Kura Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
J.P. Morgan & Co., Inc. (Old)
 J.P. Morgan & Co., Inc. (Old) Regional BanksFinance Provides commercial banking and investment advisory services | Finance |
Boston College
 Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wells Fargo Securities LLC
Wells Fargo Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
The Leonard N Stern School of Business
 The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Repare Therapeutics, Inc.
 Repare Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery and development of novel cancer therapies | Health Technology |
Onegoal New York
Onegoal New York Miscellaneous Commercial ServicesCommercial Services Operates social services organization | Commercial Services |
Hyphen Advisors LLC |
Wählen Sie MarketScreener 
